Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Trends in Pharmacological Sciences
|
January 24, 2025
Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Stem Cells (Dayton, Ohio)
|
May 13, 2022
Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes
Gian Paolo Fadini, Mattia Albiero
Current Vascular Pharmacology
|
January 14, 2012
Strategies for enhancing progenitor cell mobilization and function in diabetes
Mattia Albiero, Gian P Fadini
Metabolic Syndrome and Related Disorders
|
February 25, 2015
A perspective on sirtuins in the metabolic syndrome
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Stem Cells (Dayton, Ohio)
|
July 13, 2016
Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes
Gian Paolo Fadini, Stefano Ciciliot, Mattia Albiero
Trends in Cardiovascular Medicine
|
February 22, 2011
Circulating smooth muscle progenitors and atherosclerosis
Mattia Albiero, Lisa Menegazzo, Gian Paolo Fadini
Vascular Pharmacology
|
August 9, 2015
Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence
Gian Paolo Fadini, Mattia Albiero, Angelo Avogaro
Vascular Pharmacology
|
February 2, 2013
Restoring stem cell mobilization to promote vascular repair in diabetes
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Current Pharmaceutical Design
|
February 19, 2014
Circulating cellular players in vascular calcification
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Current Opinion in Pharmacology
|
December 3, 2020
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps
Mattia Albiero, Benedetta Maria Bonora, Gian Paolo Fadini
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Trends in Pharmacological Sciences
|
January 24, 2025
Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Stem Cells (Dayton, Ohio)
|
May 13, 2022
Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes
Gian Paolo Fadini, Mattia Albiero
Current Vascular Pharmacology
|
January 14, 2012
Strategies for enhancing progenitor cell mobilization and function in diabetes
Mattia Albiero, Gian P Fadini
Metabolic Syndrome and Related Disorders
|
February 25, 2015
A perspective on sirtuins in the metabolic syndrome
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Stem Cells (Dayton, Ohio)
|
July 13, 2016
Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes
Gian Paolo Fadini, Stefano Ciciliot, Mattia Albiero
Trends in Cardiovascular Medicine
|
February 22, 2011
Circulating smooth muscle progenitors and atherosclerosis
Mattia Albiero, Lisa Menegazzo, Gian Paolo Fadini
Vascular Pharmacology
|
August 9, 2015
Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence
Gian Paolo Fadini, Mattia Albiero, Angelo Avogaro
Vascular Pharmacology
|
February 2, 2013
Restoring stem cell mobilization to promote vascular repair in diabetes
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Current Pharmaceutical Design
|
February 19, 2014
Circulating cellular players in vascular calcification
Mattia Albiero, Angelo Avogaro, Gian Paolo Fadini
Current Opinion in Pharmacology
|
December 3, 2020
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps
Mattia Albiero, Benedetta Maria Bonora, Gian Paolo Fadini
Page
of 9